tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Willoughby, 31 are a BUY (67.39%), 13 are a HOLD (28.26%), 2 are a SELL (4.35%).
Analyst Robert Willoughby, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 42.86% that have a potential upside of 6.03% achieved within 31 days.
Robert Willoughby’s has documented 84 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CVS, CVS Health Corp at 08-Aug-2022.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 3/8/2017. The price target of $110 was fulfilled within 7 days with a profit of $6.28 (6.05%) receiving and performance score of 8.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Oct-2019
$200
$26 (14.94%)
$200
12 days ago
(26-Feb-2026)
4/5 (80%)
$10.8 (5.71%)
158
Buy Since 14-Feb-2025
$200
$26 (14.94%)
$181
1 months 5 days ago
(05-Feb-2026)
1/5 (20%)
$24.38 (13.88%)
99
Buy Since 01-May-2025
$220
$46 (26.44%)
$200
1 months 5 days ago
(05-Feb-2026)
16/49 (32.65%)
$44.38 (25.27%)
101
Hold Since 27-Oct-2023
$185
$11 (6.32%)
$155
1 months 5 days ago
(05-Feb-2026)
12/19 (63.16%)
$9.38 (5.34%)
107
Buy Since 18-Oct-2013
$210
$36 (20.69%)
$200
1 months 5 days ago
(05-Feb-2026)
29/47 (61.7%)
$34.38 (19.58%)
144
What Year was the first public recommendation made by Robert Willoughby?
